The cardiovascular perils of cancer survivorship

New England Journal of Medicine

Volumn 368, Issue 11, 2013, Pages 1055-1056

  Moslehi, Javid ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; VASCULOTROPIN;

ATHEROSCLEROSIS; BREAST CANCER; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVOR; CARDIOVASCULAR RISK; EDITORIAL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MASTECTOMY; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK FACTOR;

EID: 84874974050     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1215300     Document Type: Editorial

References (9)

1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-41. [Erratum, CA Cancer J Clin 2012;62:348.]
2. Buchholz TA. Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med 2009;360:63-70.
3. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-65. (Pubitemid 41051933)
4. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987-98.
5. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. (Pubitemid 39208455)
6. Gotto AM Jr. The Multiple Risk Factor Intervention Trial (MRFIT): a return to a landmark trial. JAMA 1997;277:595-7. (Pubitemid 27083991)
7. Khouri MG, Douglas PS, Mackey JR, et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation 2012;126:2749-63.
8. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 2010;102:14-25.
9. Bair SM, Choueiri TK, Moslehi J. Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives. Trends Cardiovasc Med (in press).